Testing a new device for heart device lead removal
Part of Heart & circulation clinical trials.
This trial tests the safety and early performance of the Xtrac O.S. system, a new tool designed to remove old pacemaker or defibrillator leads. It may help patients who need their leads taken out after being in place for 1 to 5 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You are scheduled to have a heart device lead removed based on current medical guidelines.
- Your lead has been in place for more than 1 year but less than 5 years.
- Your lead is about the thickness of a coffee stirrer (7 to 9 French).
- You are in stable health (classified as ASA II or III).
- You do not have severe heart failure (NYHA class IV) or an allergic reaction to contrast dye.
- You have tested negative for COVID-19 and have no symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new type of single-chamber pacemaker (called ALPs) for people who need a pacemaker due to a slow heart rate (heart block), often with atrial fibrillation. It's a leadless device that is placed directly inside the heart, avoiding the need for wires.
This trial tests a new pacemaker system for people who need a pacemaker for a slow or irregular heartbeat. It aims to see if the system is safe and works well.
This trial is testing a new type of pacemaker system. It may be an option for adults who need a single-chamber ventricular pacemaker and are generally in good health.
This trial studies a small, leadless pacemaker that is placed directly in the heart to treat slow heart rhythms. It's designed for people who need a pacemaker for the bottom chambers of the heart.
This study tests a new pacing lead designed to be placed in the wall between the heart's lower chambers (septum). It aims to see if this lead is safe and works well for people who need a new pacemaker.
This trial tests a new single chamber pacemaker (ALPs) for people with certain slow heart rhythms (like high-grade AV block with atrial fibrillation, or sick sinus syndrome). It's designed for those who need only one lead in the heart and may have difficulty with a standard dual-lead pacemaker.
Hear when a new Bradycardia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.